Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation water content measured by lung - A randomized clinical study

Study objective: In order to assess the effects of inhaled nitric oxide (iNO) in preventing early-onset lung edema from occurring after lung transplantation, we measured extravascular lung water (EVLW) in a group of lung transplant recipients who were at high risk for developing ischemia-reperfusion-induced lung in jury. Design: Prospective, randomized study. Settings: Surgical ICU in a teaching hospital. Patients: Thirty double-lung transplant recipients. Interventions: Patients were randomized to receive or not receive 20 ppm WO at the time of reperfusion (ic, before any occurrence of lung edema). In the NO group, iNO was then administered for a 12-h period. A double-dilution technique was used for the serial assessment of EVLW, intrathoracic blood volume, and cardiac index. Standard hemodynamic and pulmonary parameters were also recorded during the first 3 postoperative days. Measurements and results: Patients who received WO did not have a different lung water content compared to control subjects (p = 0.61 [by analysis of variance (ANOVA)]). Blood oxygenation (ie, PaO2/fraction of inspired oxygen [FiO(2)] ratio) did not differ between the two groups (p = 0.61 [by ANOVA]). In both groups, EVLW and PaO2/FiO(2) ratio dropped significantly over time, regardless of the use of iNO (p < 0.01 [by ANOVA]). Conclusions: In the population studied, prophylactic iNO that was administered at 20 ppm had no effect on pulmonary edema formation and resolution following lung transplantation.